Literature DB >> 22495688

Serotonin transporter genotype differentially modulates neural responses to emotional words following tryptophan depletion in patients recovered from depression and healthy volunteers.

Jonathan P Roiser1, Jamey Levy, Stephen J Fromm, David Goldman, Colin A Hodgkinson, Gregor Hasler, Barbara J Sahakian, Wayne C Drevets.   

Abstract

Previous studies have suggested that polymorphism in the serotonin transporter gene (5-HTTLPR) influences responses to serotonergic manipulation, with opposite effects in patients recovered from depression (rMDD) and controls. Here we sought to clarify the neurocognitive mechanisms underpinning these surprising results. Twenty controls and 23 rMDD subjects completed the study; functional magnetic resonance imaging (fMRI) and genotype data were available for 17 rMDD subjects and 16 controls. Following tryptophan or sham depletion, subjects performed an emotional-processing task during fMRI. Although no genotype effects on mood were identified, significant genotype*diagnosis*depletion interactions were observed in the hippocampus and subgenual cingulate in response to emotionally valenced words. In both regions, tryptophan depletion increased responses to negative words, relative to positive words, in high-expression controls, previously identified as being at low-risk for mood change following this procedure. By contrast, in higher-risk low-expression controls and high-expression rMDD subjects, tryptophan depletion had the opposite effect. Increased neural responses to negative words following tryptophan depletion may reflect an adaptive mechanism promoting resilience to mood change following perturbation of the serotonin system, which is reversed in sub-groups vulnerable to developing depressive symptoms. However, this interpretation is complicated by our failure to replicate previous findings of increased negative mood following tryptophan depletion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22495688      PMCID: PMC3506165          DOI: 10.1177/0269881112442789

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  46 in total

Review 1.  Sifting the evidence-what's wrong with significance tests?

Authors:  J A Sterne; G Davey Smith
Journal:  BMJ       Date:  2001-01-27

2.  Selective attention to emotional stimuli in a verbal go/no-go task: an fMRI study.

Authors:  R Elliott; J S Rubinsztein; B J Sahakian; R J Dolan
Journal:  Neuroreport       Date:  2000-06-05       Impact factor: 1.837

3.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets.

Authors:  Joseph A Maldjian; Paul J Laurienti; Robert A Kraft; Jonathan H Burdette
Journal:  Neuroimage       Date:  2003-07       Impact factor: 6.556

4.  Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion.

Authors:  F A Moreno; D C Rowe; B Kaiser; D Chase; T Michaels; J Gelernter; P L Delgado
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

5.  Association of the 5- HTTLPR genotype and unipolar depression: a meta-analysis.

Authors:  H Clarke; J Flint; A S Attwood; M R Munafò
Journal:  Psychol Med       Date:  2010-04-12       Impact factor: 7.723

6.  Emotional bias and inhibitory control processes in mania and depression.

Authors:  F C Murphy; B J Sahakian; J S Rubinsztein; A Michael; R D Rogers; T W Robbins; E S Paykel
Journal:  Psychol Med       Date:  1999-11       Impact factor: 7.723

7.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

8.  The neural basis of mood-congruent processing biases in depression.

Authors:  Rebecca Elliott; Judy S Rubinsztein; Barbara J Sahakian; Raymond J Dolan
Journal:  Arch Gen Psychiatry       Date:  2002-07

9.  Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression.

Authors:  Alexander Neumeister; Anastasios Konstantinidis; Juergen Stastny; Markus J Schwarz; Oliver Vitouch; Matthaus Willeit; Nicole Praschak-Rieder; Johanna Zach; Martina de Zwaan; Brigitta Bondy; Manfred Ackenheil; Siegfried Kasper
Journal:  Arch Gen Psychiatry       Date:  2002-07

10.  The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers.

Authors:  F C Murphy; K A Smith; P J Cowen; T W Robbins; B J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2002-07-13       Impact factor: 4.530

View more
  3 in total

1.  Association Study of Genotype by Depressive Response during Tryptophan Depletion in Subjects Recovered from Major Depression.

Authors:  Francisco A Moreno; Robert P Erickson; Holly A Garriock; Joel Gelernter; Jim Mintz; Jennifer Oas-Terpstra; Marilyn A Davies; Pedro L Delgado
Journal:  Mol Neuropsychiatry       Date:  2015-09-24

2.  Monoamine polygenic liability in health and cocaine dependence: imaging genetics study of aversive processing and associations with depression symptomatology.

Authors:  Scott J Moeller; Muhammad A Parvaz; Elena Shumay; Salina Wu; Nicasia Beebe-Wang; Anna B Konova; Michail Misyrlis; Nelly Alia-Klein; Rita Z Goldstein
Journal:  Drug Alcohol Depend       Date:  2014-04-28       Impact factor: 4.492

3.  Using the affective bias test to predict drug-induced negative affect: implications for drug safety.

Authors:  S A Stuart; C M Wood; E S J Robinson
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.